Clinical Trials Browser

Phase 1/2 × Carcinoma, Non-Small-Cell Lung × tanespimycin × Clear all

NCT01427946 2014-11-13

Phase 1b/2 Study of Retaspimycin HCl (IPI-504) in Combination With Everolimus in KRAS Mutant Non-small Cell Lung Cancer

Phase 1/2 Completed

Carcinoma, Non-Small-Cell Lung

NCT00431015 2012-12-10

Phase I/II Safety Study of IPI-504 in Relapsed/Refractory Stage IIIb, or Stage IV Non-small Cell Lung Cancer (NSCLC)

Phase 1/2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms